首页|右美托咪定联合丙泊酚静脉麻醉在儿童肿瘤患者放射治疗中的安全性研究

右美托咪定联合丙泊酚静脉麻醉在儿童肿瘤患者放射治疗中的安全性研究

扫码查看
目的 评价右美托咪定联合丙泊酚在儿童肿瘤静脉麻醉放射治疗中的安全性。方法 选取 2016 年 10 月~2022 年 5 月在郑州市第三人民医院行静脉麻醉下放疗的 82 例儿童肿瘤患者,非插管静脉麻醉共 1 256 次,采用随机数字表法分为丙泊酚麻醉组(P组)41 例,静脉麻醉 628 次;右美托咪定联合丙泊酚麻醉组(D+P组)41 例,静脉麻醉628 次。观察比较两组患儿在不同麻醉方式下放疗前(麻醉前)、放疗后(麻醉后)呼吸频率、心率、氧饱和度的变化,计算丙泊酚给药次数、丙泊酚用量,计算患儿麻醉后入睡至放疗结束后清醒的时间间隔,并统计两组不良反应发生情况。结果 P组与D+P组患儿放疗前后的心率、呼吸频率、氧饱和度差异无统计学意义(均P>0。05);两组患儿放疗前后心率和呼吸频率差异均无统计学意义(均P>0。05),两组患儿放疗前后氧饱和度差异有统计学意义(P<0。05)。两组麻醉苏醒时间差异无统计学意义(P>0。05),D+P组丙泊酚给药次数减少、用药剂量减少。P组不良反应发生率为 63。41%,D+P组不良反应发生率为 12。19%,两组比较差异有统计学意义(P<0。05)。结论 丙泊酚及右美托咪定联合丙泊酚在儿童肿瘤静脉麻醉放疗过程中,安全性均较好,其中右美托咪定联合丙泊酚组麻醉苏醒时间未见明显延长,丙泊酚给药次数减少,用药剂量减少,不良反应小,值得临床推广应用。
Study on the safty of dexmedetomidine combined with propofol intravenous anesthesia in radiotherapy for children with tumor
Objective To evaluate the safety of dexmedetomidine combined with propofol intravenous anesthesia radiotherapy of children with tumor.Methods Eighty two pediatric tumor patients who underwent intravenous anesthesia radiotherapy in the Third People's Hospital of Zhengzhou from Oct 2016 to May 2022 were selected.A total of 1 256 times of non intubated intravenous anesthesia were used.The patients were randomly divided into two groups:propofol anesthesia group(group P),41 cases,628 times of intravenous anesthesia;41 cases in dexmedetomidine combined with propofol anesthesia group(group D+P),and 628 times of intravenous anesthesia.The changes of respiratory rate,heart rate and oxygen saturation before(before anesthesia)and after(after anesthesia)radiotherapy under different anesthesia methods were observed and compared between the two groups.The times of propofol administration and the dosage of propofol were calculated.The time interval from children falling asleep after anesthesia to awake after radiotherapy was calculated,and the occurrence of adverse reactions in the two groups was counted.Results There were no significant differences in heart rate,respiratory rate and oxygen saturation between group P and group D+P before and after radiotherapy(P>0.05);there were no significant differences in heart rate and respiratory rate between the two groups before and after radiotherapy(P>0.05),but there was significant difference in oxygen saturation between the two groups before and after radiotherapy(P<0.05).There was no statistically significant difference in the recovery time of anesthesia between the two groups.The number of propofol administrations and the dosage of propofol were reduced in the group D+P.The incidence of adverse reactions was 63.41%in group P and 12.19%in group D+P,with significant difference between the two groups(P<0.05).Conclusion Propofol and dexmedetomidine combined with propofol have good safety in the process of intravenous anesthesia and radiotherapy for children with tumor.The anesthesia recovery time of dexmedetomidine combined with propofol was not significantly prolonged.The administration times of propofol are reduced,the dosage is reduced,and the adverse reactions are small,which is worthy of clinical application.

Children with tumorRadiotherapyIntravenous anesthesiaPropofolDexmedetomidine

王书君、陈公安、张伟、王贺玲、王刚、郑晓

展开 >

郑州市第三人民医院肿瘤放疗科,河南郑州 450000

中国科学院大学附属浙江省肿瘤医院放射治疗科,浙江杭州 310005

儿童肿瘤 放射治疗 静脉麻醉 丙泊酚 右美托咪定

河南省医学科技攻关计划项目

LHGJ20210739

2024

中国现代医药杂志
北京航天总医院

中国现代医药杂志

影响因子:0.689
ISSN:1672-9463
年,卷(期):2024.26(9)